225
Participants
Start Date
June 18, 2019
Primary Completion Date
June 30, 2026
Study Completion Date
December 30, 2030
remede System
Patients undergoing a remede System implant attempt. Study devices will be used per approved indications for use for each geography.
New York Presbyterian Hospital-Weill Cornell Medicine, New York
Northwell Health, New Hyde Park
Penn State Health Milton S. Hershey Medical Center, Hershey
Hospital of the University of Pennsylvania, Philadelphia
Thomas Jefferson University, Philadelphia
West Virginia University, Morgantown
Novant Health Forsyth Medical Center, Winston-Salem
East Carolina University, Greenville
Novant Health - Charlotte, Charlotte
Emory University Midtown Hospital, Atlanta
Central Florida Pulmonary Group, Orlando
Baptist Health Lexington, Lexington
Ohio Sleep Medicine Institute, Dublin
The Ohio State Wexner Medical Center, Columbus
University of Michigan Health West, Wyoming
Mayo Clinic, Rochester
Monument Health, Rapid City
University of Chicago, Chicago
St. Luke's Mid America Heart Institute, Kansas City
Oklahoma Heart Institute, Tulsa
Baylor Scott and White - Dallas, Dallas
University of Colorado- Anschutz, Aurora
University of Colorado Health, Fort Collins
Banner University Medical Center, Phoenix
Arizona Heart Rhythm Center, Phoenix
HonorHealth, Scottsdale
New Mexico Heart Institute - Lovelace Medical Center, Albuquerque
The University of California San Francisco, San Francisco
The Valley Hospital, Paramus
OLVG Amsterdam, Amsterdam
Amphia Longresearch, Breda
Medisch Spectrum Twente, Enschede
Respicardia, Inc.
INDUSTRY